Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients
Open Access
- 16 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e77326
Abstract
Insulin-resistance is commonly found in adrenal incidentaloma (AI) patients. However, little is known about beta-cell secretion in AI, because comparisons are difficult, since beta–cell-function varies with altered insulin-sensitivity. To retrospectively analyze beta–cell function in non-diabetic AI, compared to healthy controls (CON). AI (n=217, 34%males, 57±1years, body-mass-index:27.7±0.3kg/m2) and CON [n=25, 32%males, 56±1years, 26.7±0.8kg/m2] with comparable anthropometry (p≥0.31) underwent oral-glucose-tolerance-tests (OGTTs) with glucose, insulin, and C–peptide measurements. 1mg-dexamethasone-suppression-tests were performed in AI. AI were divided according to post–dexamethasone-suppression–test cortisol-thresholds of 1.8 and 5µg/dL into 3subgroups: pDexa5µg/dL. Using mathematical modeling, whole-body insulin-sensitivity [Clamp-like-Index (CLIX)], insulinogenic Index, Disposition Index, Adaptation Index, and hepatic insulin extraction were calculated. CLIX was lower in AI combined (4.9±0.2mg·kg-1·min-1), pDexa<1.8µg/dL (4.9±0.3) and pDexa1.8-5µg/dL (4.7±0.3, p<0.04 vs.CON:6.7±0.4). Insulinogenic and Disposition Indexes were 35%–97% higher in AI and each subgroup (p<0.008 vs.CON), whereas C–peptide–derived Adaptation Index, compensating for insulin-resistance, was comparable between AI, subgroups, and CON. Mathematical estimation of insulin–derived (insulinogenic and Disposition) Indexes from associations to insulin-sensitivity in CON revealed that AI-subgroups had ~19%-32% higher insulin-secretion than expectable. These insulin-secretion-index differences negatively (r=-0.45, p<0.001) correlated with hepatic insulin extraction, which was 13-16% lower in AI and subgroups (p<0.003 vs.CON). AI-patients show insulin-resistance, but adequately adapted insulin secretion with higher insulin concentrations during an OGTT, because of decreased hepatic insulin extraction; this finding affects all AI-patients, regardless of dexamethasone-suppression-test outcome.Keywords
This publication has 40 references indexed in Scilit:
- Glucose Absorption in Gestational Diabetes Mellitus During an Oral Glucose Tolerance TestDiabetes Care, 2011
- Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Insulin Infusion During Normoglycemia Modulates Insulin Secretion According to Whole-Body Insulin SensitivityDiabetes Care, 2011
- The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?The Journal of Physiology, 2010
- Novel Aspects on Insulin ResistanceThe Endocrinologist, 2009
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2008
- Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: A sign of impaired -cell function?Diabetes Care, 2006
- Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescentsActa Paediatrica, 1998
- Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs.Journal of Clinical Investigation, 1986
- PHAEOCHROMOCYTOMA AND DIABETES MELLITUS: FURTHER EVIDENCE THAT α2 RECEPTORS INHIBIT INSULIN RELEASE IN MANClinical Endocrinology, 1983